PS
CANC icon

Principal Securities’s Tema Oncology ETF CANC Stock Holding History

Principal Securities’s Portfolio CANC Stock Details CANC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50
Closed -$1.44K – 1660
2025
Q3 		$1.44K Hold
50
– – ﹤0.01% 3315
2025
Q2 		$1.24K Hold
50
– – ﹤0.01% 3279
2025
Q1 		$1.22K Buy
+50
New +$1.26K ﹤0.01% 3163

Other funds holding CANC

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
WF
Willow Financial Rogers, Arkansas $98.7M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TCM
TD Capital Management Memphis, Tennessee $1.22B AUM 13.44% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Principal Securities's CANC Position: Q4 2025 in Review

Principal Securities sold out of Tema Oncology ETF (CANC) in Q4 2025, closing a stake of 50 shares — an estimated $1.44K sold.

Principal Securities first reported a position in CANC in Q1 2025 and held it in 3 quarters. The position peaked at $1.44K in Q3 2025. 6 funds tracked by Wall St. Rank hold CANC as of Q4 2025.

  • Principal Securities reported no remaining Tema Oncology ETF position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 50 Tema Oncology ETF shares in Q4 2025, an estimated $1.44K.
  • Principal Securities first reported a position in Tema Oncology ETF in Q1 2025 and held it in 3 quarters.
  • Principal Securities's Tema Oncology ETF position peaked at $1.44K in Q3 2025.
  • 6 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.